Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,170 | 100 | 438 | 1,348 | 2,462 |
| Receivables | 2 | 10 | 1 | 88 | N/A |
| Other current assets | 28 | 50 | 51 | 130 | 154 |
| TOTAL | $2,200 | $160 | $490 | $1,566 | $2,616 |
| Non-Current Assets | |||||
| PPE Net | 1,000 | 1,040 | 422 | 673 | 681 |
| Other Non-Current Assets | 550 | 510 | 0 | 0 | 0 |
| TOTAL | $1,550 | $1,550 | $422 | $673 | $681 |
| Total Assets | $3,040 | $1,050 | $1,447 | $2,376 | $2,959 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 390 | 390 | 0 | 0 | 0 |
| Accrued Expenses | 10 | 20 | N/A | N/A | N/A |
| Other current liabilities | 0 | 50 | N/A | N/A | N/A |
| TOTAL | $490 | $600 | $706 | $348 | $411 |
| Non-Current Liabilities | |||||
| TOTAL | $70 | $110 | $N/A | $N/A | $N/A |
| Total Liabilities | $560 | $720 | $706 | $348 | $411 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 1,490 | 1,304 | 1,280 | 1,256 |
| Retained earnings | -21,570 | -20,640 | N/A | N/A | N/A |
| Other shareholders' equity | 10 | 10 | -705 | 592 | 1,128 |
| TOTAL | $2,480 | $330 | $599 | $1,872 | $2,384 |
| Total Liabilities And Equity | $3,040 | $1,050 | $1,305 | $2,220 | $2,795 |